Symbotic Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020
Cash & Equivalents	258.77	353.46	156.63	58.26
Short-Term Investments	286.74	0	0	0
Cash & Cash Equivalents	545.51	353.46	156.63	58.26
Cash Growth	54.33%	125.66%	168.83%	-
Receivables	190.36	105.23	63.37	2.49
Inventory	136.12	91.9	33.56	16.45
Other Current Assets	119.81	54.81	6.86	134.32
Total Current Assets	991.8	605.4	260.42	211.53
Property, Plant & Equipment	34.51	24.88	18.62	9.19
Goodwill and Intangibles	0.22	0.65	1.16	1.54
Other Long-Term Assets	24.19	0.34	0.33	2.7
Total Long-Term Assets	58.92	25.87	20.12	13.43
Total Assets	1,051	631.26	280.54	224.95
Accounts Payable	109.92	68.45	28.02	5.96
Deferred Revenue	787.23	425.71	475.96	380.78
Other Current Liabilities	128.31	28.8	-167	-240.18
Total Current Liabilities	1,025	522.96	336.97	146.56
Other Long-Term Liabilities	27.97	39.37	220.53	262.47
Total Long-Term Liabilities	27.97	39.37	220.53	262.47
Total Liabilities	1,053	562.32	557.5	409.03
Retained Earnings	-1,310.44	-1,286.57	-1,154.94	-856.86
Comprehensive Income	-1.69	-2.29	-2.09	-4.42
Shareholders' Equity	0.08	7.18	-1,113.23	-844.47
Net Cash / Debt	545.51	353.46	156.63	58.26
Net Cash / Debt Growth	54.33%	125.66%	168.83%	-
Net Cash Per Share	8.48	6.54	24.37	9.07
Working Capital	-33.66	82.44	-76.55	64.97
Book Value Per Share	0.00	0.13	-173.23	-131.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).